PT Hetzer (Indonesia) Performance
| MEDS Stock | 50.00 0.00 0.00% |
The company owns a Beta (Systematic Risk) of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and PT Hetzer are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days PT Hetzer Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent forward-looking signals, PT Hetzer is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more
MEDS |
PT Hetzer Relative Risk vs. Return Landscape
If you would invest 5,000 in PT Hetzer Medical on December 23, 2024 and sell it today you would earn a total of 0.00 from holding PT Hetzer Medical or generate 0.0% return on investment over 90 days. PT Hetzer Medical is generating negative expected returns and assumes 0.0% volatility on return distribution over the 90 days horizon. Simply put, 0% of stocks are less volatile than MEDS, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
PT Hetzer Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PT Hetzer's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PT Hetzer Medical, and traders can use it to determine the average amount a PT Hetzer's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MEDS |
Based on monthly moving average PT Hetzer is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PT Hetzer by adding PT Hetzer to a well-diversified portfolio.
PT Hetzer Fundamentals Growth
MEDS Stock prices reflect investors' perceptions of the future prospects and financial health of PT Hetzer, and PT Hetzer fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MEDS Stock performance.
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.12 % | |||
| Shares Outstanding | 1.56 B | |||
| Price To Sales | 5.97 X | |||
| Revenue | 43.99 B | |||
| EBITDA | 7.68 B | |||
| Book Value Per Share | 45.78 X | |||
About PT Hetzer Performance
By examining PT Hetzer's fundamental ratios, stakeholders can obtain critical insights into PT Hetzer's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that PT Hetzer is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about PT Hetzer Medical performance evaluation
Checking the ongoing alerts about PT Hetzer for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PT Hetzer Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PT Hetzer Medical generated a negative expected return over the last 90 days |
- Analyzing PT Hetzer's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PT Hetzer's stock is overvalued or undervalued compared to its peers.
- Examining PT Hetzer's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PT Hetzer's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PT Hetzer's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PT Hetzer's stock. These opinions can provide insight into PT Hetzer's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in MEDS Stock
PT Hetzer financial ratios help investors to determine whether MEDS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MEDS with respect to the benefits of owning PT Hetzer security.